SAFETY OF VEDOLIZUMAB USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引：1
|
作者：
Shivashankar, Raina
Ladd, Antonio H. Mendoza
Grace, Rory
Aberra, Faten
Lichtenstein, Gary R.
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)32104-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1888
引用
收藏
页码：S585 / S585
页数：1
相关论文
共 50 条
  • [31] Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease
    Christensen, Britt
    Gibson, Peter R.
    Micic, Dejan
    Colman, Ruben J.
    Goeppinger, Sarah R.
    Kassim, Olufemi
    Yarur, Andres
    Weber, Christopher R.
    Cohen, Russell D.
    Rubin, David T.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 486 - 493
  • [32] Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study
    Ruth Garcia-Romero
    José Miguel Martinez de Zabarte Fernandez
    Gemma Pujol-Muncunill
    Ester Donat-Aliaga
    Oscar Segarra-Cantón
    Iñaki Irastorza-Terradillos
    Enrique Medina-Benitez
    Carlos José Ruiz-Hernández
    Marta Carrillo-Palau
    Ignacio Ros-Arnal
    Alejandro Rodriguez-Martínez
    Laura Escartin-Madurga
    Carolina Gutiérrez-Junquera
    Saioa Vicente-Santamaría
    Marta Velasco Rodriguez-Belvis
    Sonia Fernández-Fernández
    José Ramón Alberto-Alonso
    Montserrat Montraveta
    Ricardo Torres-Peral
    María Navalon-Rubio
    Víctor Manuel Navas-López
    Javier Martin de Carpi
    [J]. European Journal of Pediatrics, 2021, 180 : 3029 - 3038
  • [33] VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Haddley, K.
    [J]. DRUGS OF TODAY, 2014, 50 (04) : 309 - 319
  • [34] Vedolizumab (Entyvio) for Inflammatory Bowel Disease
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1451): : 86 - 88
  • [35] Safety and effectiveness of vedolizumab for the treatment of paediatric patients with Inflammatory Bowel Diseases
    Fabiszewska, S.
    Derda, E.
    Szymanska, E.
    Osiecki, M.
    Kierkus, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I498 - I498
  • [36] Safety and effectiveness of vedolizumab for the treatment of paediatric patients with Inflammatory Bowel Diseases
    Fabiszewska, S.
    Derda, E.
    Szymanska, E.
    Osiecki, M.
    Kierkus, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I498 - I498
  • [37] Variability in Vedolizumab Exposure Between Patients With Inflammatory Bowel Disease
    Gils, Ann
    Dreesen, Erwin
    Peeters, Miet
    Brouwers, Els
    Ferrante, Marc
    Van Assche, Gert
    Vermeire, Severine
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S411 - S412
  • [38] Articular Manifestations in Patients with Inflammatory Bowel Disease Treated with Vedolizumab
    Dupre, Anastasia
    Collins, Michael
    Carbonnel, Franck
    Mariette, Xavier
    Seror, Raphaele
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [39] Therapeutic Drug Monitoring in Inflammatory Bowel Disease Patients on Vedolizumab
    Ansari, Mohammed
    Glassner, Kerri
    Irani, Malcolm
    Perry, Caroline
    Abraham, Bincy P.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S435 - S436
  • [40] Articular manifestations in patients with inflammatory bowel disease treated with vedolizumab
    Dupre, Anastasia
    Collins, Michael
    Nocturne, Gaetane
    Carbonnel, Franck
    Mariette, Xavier
    Seror, Raphaele
    [J]. RHEUMATOLOGY, 2020, 59 (11) : 3275 - 3283
12345